Foley J A, Becker R C
Cardiovasc Drugs Ther. 1996 Sep;10(4):403-7. doi: 10.1007/BF00051103.
Calcium channel antagonists are among the world's most widely prescribed class of drugs and are used most often in patients with hypertension and coronary artery disease. However, in the recent past serious questions have been raised concerning their potentially detrimental effects. One area of considerable clinical importance that deserves close inspection is the role of calcium channel antagonists following coronary reperfusion. Specifically, is there benefit or detriment?
钙通道拮抗剂是世界上处方量最广泛的一类药物，最常用于高血压和冠心病患者。然而，最近人们对其潜在的有害影响提出了严重质疑。一个具有相当临床重要性且值得密切关注的领域是钙通道拮抗剂在冠状动脉再灌注后的作用。具体而言，是有益还是有害？
